- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 187 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- November 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- October 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- January 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,423GBP
- Report
- September 2021
- 116 Pages
Global
From €720EUR$749USD£618GBP
- Report
- May 2021
- 381 Pages
Global
From €4611EUR$4,799USD£3,958GBP
- Report
- September 2022
- 95 Pages
Global
From €4084EUR$4,250USD£3,506GBP
- Report
- May 2024
- 262 Pages
From €5381EUR$5,600USD£4,619GBP
- Report
- July 2020
- 13 Pages
Global
From €956EUR$995USD£821GBP
- Book
- October 2012
- 1570 Pages
The Tuberculosis Vaccine market is a segment of the Vaccines industry that focuses on the development and distribution of vaccines to prevent the spread of tuberculosis (TB). TB is a highly contagious bacterial infection that can cause serious illness and death. Vaccines are the most effective way to prevent the spread of TB, and the market for TB vaccines is growing as more countries recognize the need for immunization.
The market for TB vaccines is highly competitive, with many companies developing and distributing vaccines. Companies in the market include GlaxoSmithKline, Sanofi Pasteur, Merck, and Pfizer. These companies are working to develop new and improved vaccines to help reduce the spread of TB and improve public health. Show Less Read more
